Genelux (GNLX) Enterprise Value (2023 - 2026)
Genelux (GNLX) posted Enterprise Value of $86.6 million for Q1 2026, down 43.81% on a QoQ basis from $154.1 million in Q4 2025, and down 1.71% year-over-year from $88.1 million in Q1 2025.
Analysis
Genelux (GNLX) Enterprise Value (2023 - 2026) Analysis & Trends
Genelux has reported Enterprise Value for 4 years, with the latest figure at $86.6 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 1.71% year-over-year to $86.6 million in Q1 2026; TTM through Mar 2026 was $86.6 million, a 1.71% decrease from a year earlier, with the FY2025 full-year figure at $154.1 million, up 418.4% from the prior year.
- Enterprise Value was $86.6 million for Q1 2026 at Genelux, down from $154.1 million in the prior quarter.
- The five-year high for Enterprise Value was $846.0 million in Q2 2023, with the low at $1.1 million in Q2 2024.
- Average Enterprise Value over 4 years is $235.8 million, with a median of $125.6 million recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value tumbled 99.87% in 2024, then soared 5385.68% in 2025.
- Over 4 years, Enterprise Value stood at $352.1 million in 2023, then plunged by 91.56% to $29.7 million in 2024, then soared by 418.4% to $154.1 million in 2025, then tumbled by 43.81% to $86.6 million in 2026.
- The last three Enterprise Value figures came in at $86.6 million (Q1 2026), $154.1 million (Q4 2025), and $125.6 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Genelux | 108.17 Mn | 108.17 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 86.57 Mn |
| Dec 31, 2025 | 154.07 Mn |
| Sep 30, 2025 | 125.57 Mn |
| Jun 30, 2025 | 58.84 Mn |
| Mar 31, 2025 | 88.08 Mn |
| Dec 31, 2024 | 29.72 Mn |
| Sep 30, 2024 | 18.84 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 138.40 Mn |
| Dec 31, 2023 | 352.12 Mn |
| Sep 30, 2023 | 622.98 Mn |
| Jun 30, 2023 | 845.99 Mn |
| Mar 31, 2023 | 543.03 Mn |